More Company News

Redx Pharma

Phase II dose selection of RXC004
27 Jul 2021Read More

Redx Pharma

Receipt of $4m RXC004 milestone payment
17 Jun 2021Read More

Redx Pharma

Interim H121 results
07 Jun 2021Read More

Redx Pharma

First subject dosed in RXC007 Phase I study
03 Jun 2021Read More

Redx Pharma

Appointment of Peter Collum as CFO
05 May 2021Read More

Redx Pharma

First patients dosed with RX004 and anti-PD-1
28 Apr 2021Read More

Redx Pharma

FY20 results and operational update
27 Jan 2021Read More

Redx Pharma

Results of Open Offer and General Meeting
21 Dec 2020Read More

Redx Pharma

£25.5m placing and open offer
02 Dec 2020Read More

Redx Pharma

Appointment of Chief Medical Officer
27 Oct 2020Read More

1 2
Return to Redx Pharma
© 2019-21 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).